|Bid||0.0950 x 0|
|Ask||0.1000 x 0|
|Day's Range||0.0950 - 0.1000|
|52 Week Range||0.0900 - 0.9400|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
FSD Pharma (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) has launched its online ordering system for the direct fulfillment of medicinal cannabis orders. Clients having a prescription from a medical practitioner or a registration number with Health Canada can now place an order online for dried cannabis on FVPharma.com. FSD Pharma subsidiary FV Pharma will handle the system. "The launch of a functional online ordering portal […]The post FSD Pharma Launches Online System for Medicinal Cannabis Orders appeared first on Market Exclusive.
FSD Pharma (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) and US-based specialty R&D pharmaceutical company Prismic Pharmaceuticals finalized a deal for the acquisition of all of the issued and outstanding securities of Prismic by FSD Pharma. Under to the terms of a securities exchange agreement, FSD Pharma has acquired all outstanding common and preferred shares of […]The post FSD Pharma Acquires Prismic Pharmaceuticals appeared first on Market Exclusive.
FSD Pharma (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced that its subsidiary FV Pharma has received its full sale for medical purposes license to sell cannabis under the Cannabis Act of Canada. The license, effective as of June 21, allows the FSD facility in Cobourg, Ontario, to supply and sell cannabis products, including dried and […]The post FSD Pharma Gets License to Sell Cannabis for Medical Use appeared first on Market Exclusive.
FSD Pharma (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) said that its FV Pharma subsidiary received its Sale For Medical Purposes license for the sale of cannabis products. The license, which went into effect on April 18, allows the current FSD facility to supply and sell cannabis products under the Cannabis Act Canada. The company anticipates […]The post FSD Pharma Gets Approval to Get Cannabis Products appeared first on Market Exclusive.
FSD Pharma (CSE: HUGE) (OTCQB: FSDDF) made a $1.5-million investment in Pharmastrip Corp. and inked an agreement with the company as part of its plans to produce cannabis products. Under the terms of the agreement, FSD will install Pharmastrip equipment at its facility in Cobourg, Ontario. The company will use the equipment to manufacture organic […]The post FSD Pharma to Use Pharmastrip Equipment to Make Cannabis-Infused Oral Strips appeared first on Market Exclusive.